Skip to main content
. 2022 Mar 13;4(1):vdac026. doi: 10.1093/noajnl/vdac026

Figure 1.

Figure 1.

 Schematic overview of the SHH signaling pathway. In inactivated status PTCH1 inhibits SMO and SUFU is bound to GLI1, GLI2 or GLI3 in cytoplasm (left panel); if SHH (ligand) binds to PTCH1 transmembranal SMO gets activated; GLI1/2/3 is released and translocted to nucleus where it functions as transcription factor (right panel); Adapted from “Hedgehog Signaling Pathway”, by BioRender.com (2021). Retrieved from https://app.biorender.com/biorender-templates.